| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| R&D Expense | $405K | -48.2% |
| Operating Income | -$1.2M | +32.4% |
| Interest Expense | $39K | +0.0% |
| Net Income | -$1.2M | +30.9% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2K | +300.4% |
| Current Assets | $2K | -85.5% |
| Total Assets | $102K | +602.9% |
| Current Liabilities | $15.6M | +12.1% |
| Total Liabilities | $15.6M | +9.3% |
| Stockholders' Equity | -$15.5M | -8.7% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$359K | +48.3% |
| Investing Cash Flow | -$100K | — |
| Financing Cash Flow | $460K | -33.8% |